CTI BioPharma Corp. (CTIC)

0.78
NASDAQ : Health Technology
Prev Close 0.75
Day Low/High 0.74 / 0.79
52 Wk Low/High 0.60 / 2.11
Avg Volume 136.10K
Exchange NASDAQ
Shares Outstanding 57.98M
Market Cap 43.48M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Stock Search: Citigroup, Ford, Bank of America

Stock Search: Citigroup, Ford, Bank of America

Citigroup climbed back atop the stock-search list on TheStreet.com today, pushing Ford down a notch. AIG, State Street and Goldman Sachs were the day's only new entries.

Biotech Stock Mailbag: Cell Therapeutics

Readers have their say on a recent bearish column about Cell Therapeutics.

Stock Search: Ford, Citi, People's United

Stock Search: Ford, Citi, People's United

Ford climbed to the top of the stock search list on TheStreet.com today, pushing Citigroup down a notch. Wells Fargo returned at No. 8 and People's United Financial appeared as the only new entry.

Choppy Trading on More Stock Offerings

Choppy Trading on More Stock Offerings

Frank Curzio's guests include David Peltier, Adam Feuerstein, and Larsen Kusick.

Biotech Rocket Stocks for the Week

Biotech Rocket Stocks for the Week

These stocks could surge higher (or lower) in the coming days.

Stock Search: Citigroup, GE, Ford, BofA

Stock Search: Citigroup, GE, Ford, BofA

Citigroup reclaimed the top position in today's stock search list on TheStreet.com, pushing GE into second place. VMware, Cell Therapeutics and Hansen Natural are new to the list.

Biotech Data Preview: ASCO's Top Stories

Biotech Data Preview: ASCO's Top Stories

Investors are watching for key data from a handful of drug trials at this year's ASCO conference.

Cell Therapeutics: Don't Fall for This Trap

Cell Therapeutics: Don't Fall for This Trap

Cell Therapeutics is not the biotech turnaround story of the year, and here's why.

You Ask, Dan Fitzpatrick Answers

Fitzpatrick recently answered Stockpickr questions about Cell Therapeutics, shipping stocks and more.

Stock Search: Citigroup, Bank of America

Banks topped today's list of the most-searched-for stocks on TheStreet.com, with Citigroup, Bank of America and Wells Fargo at the No. 1, No. 2 and No. 3 spots, respectively. Newcomers to the list include Abbott, IBM and Sprint.

Stock Search: Dendreon, Citigroup, Ford

Dendreon remains No. 1 on TheStreet.com's list of most-searched-for stocks, with Citigroup and Ford holding the No. 2 and No. 3 slots, respectively. New to today's list are Cell Therapeutics, Sequenom and GE.

Four Must-See Charts: Biotech Stocks

These speculative biotech stocks could be setting up to make significant moves in the near future.

You Ask, TheStreet.com Ratings Answers

Recently, TSC Ratings' Richard Widows answered questions about Textron, Cell Therapeutics and more.

With Spectrum, Zevalin Might Finally Have a Chance

Spectrum has a lot of work to do, but there are potentially positive signs that the company could succeed where others have failed.

Cell Therapeutics Sells Rest of Zevalin Stake

Cell Therapeutics Sells Rest of Zevalin Stake

Cell Therapeutics is selling off the remaining 50% stake in its cancer drug Zevalin for $18 million in a desperate bid to keep the company afloat.

Biotech Stock Mailbag: Panacos

Biotech Stock Mailbag: Panacos

Panacos is worth more than 12 cents -- and is worth hanging on to.

Biotech Mailbag: Cell Thera-Pew-Tics

Biotech Mailbag: Cell Thera-Pew-Tics

Investors have a least three huge reasons to avoid this company.

Biotech-Stock Mailbag: Sangamo

Biotech-Stock Mailbag: Sangamo

Weighing chances for Sangamo's lead pipeline drug, and more.

Biotech Notebook: Progenics, Wyeth

Biotech Notebook: Progenics, Wyeth

Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.

Big Money Steers Clear of Biotech

Big Money Steers Clear of Biotech

As investors shy away from risk, this week's BIO CEO confab was a bleak affair.

Feuerstein's Biotech-Stock Mailbag

BioSante Pharma's chief takes on the critics.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Noven gets a nod of approval from the FDA.

Thursday's Small-Cap Winners & Losers

Thursday's Small-Cap Winners & Losers

Security Capital Assurance plummets.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Cell Therapeutics climbs on positive preliminary study results.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Biotech stocks rose on regulatory news and analyst actions.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Cardica climbs again.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Biogen Idec climbs on upbeat revenue guidance.

Thursday's Health Winners & Losers

Amgen falls.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Neose Technologies climbs on positive drug data.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

SonoSite climbs on a rise in quarterly sales.

TheStreet Quant Rating: D (Sell)